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Background: Manufacturer-predicted stent expansion is based on in-vitro testing. Actual expansion is related to stent architecture, lesion 
characteristics, etc. We evaluated the relationships between these variables on coronary drug-eluting stent (DES) expansion during PCI via 
intravascular ultrasound (IVUS).
Methods: 1,334 IVUS frames were acquired and analyzed in 44 lesions post-DES via Volcano EagleEye Platinum 20 MHz IVUS. DES studied were 
Medtronic Endeavor (n = 32, 624 mm) and Abbott Xience V (n = 12, 215 mm), deployed at 16-22 ATM after predilatation. Expansion deficit (ED, %) 
was the ratio of observed to predicted stented cross-sectional area.
Results: Both DES were less expanded than predicted (ED = -10.2%, p<0.001) but neither evidenced malapposition. Mean ED was higher in 
Endeavor vs. Xience (-11.5% vs. -6.0%, p < 0.001, Fig 1A). 93.5% of Endeavor frames under-expanded vs. 80.4% Xience (p < .001) however Endeavor 
had less overexpansion than Xience (6.5% vs. 19.6%, p<0.001). ED was greater in ACS vs. non-ACS (-11.26% vs. -9.76%, p < .002) and LAD vs. non-
LAD lesions (-12.22% vs. -6.52%, p < .0001). The highest ED (-11.86%, p < .001) was in 3.0 mm DES. ED correlated with plaque burden (Fig 1B).
Conclusions: Actual DES expansion is less than predicted despite high-pressure deployment. Inter-stent differences and lesion/vessel-specific 
variables impact stent performance in vivo. These data have implications on stent selection/deployment and underscore the value of post-DES 
intravascular imaging. 
